Jubilant Pharmova Limited (NSE:JUBLPHARMA)
1,077.00
+9.50 (0.89%)
At close: Dec 5, 2025
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.